Maryam Razmjooei was a PhD student at Shiraz University, Iran, specializing in Food Biotechnology. In 2022, she joined the research group as a visiting scholar,
focusing on the utilization of metal-organic frameworks (MOFs), specifically PEGylated PCN-222, for the encapsulation of insulin as an oral delivery system.
Her research explored nanoparticle behavior, including in vitro release in simulated gastrointestinal conditions and the cellular uptake of PEG@PCN-222@insulin
using Caco-2 and HT29-MTX-E12 cell lines.